hematoxylin has been researched along with Epithelial Ovarian Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boldrini, L; Fagotti, A; Giudice, MT; Inzani, F; Lenkowicz, J; Minucci, A; Nero, C; Pasciuto, T; Piermattei, A; Scambia, G; Valentini, V; Zannoni, G | 1 |
1 other study(ies) available for hematoxylin and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer.
Topics: BRCA1 Protein; Carcinoma, Ovarian Epithelial; Deep Learning; Eosine Yellowish-(YS); Female; Germ-Line Mutation; Hematoxylin; Humans; Mutation; Ovarian Neoplasms | 2022 |